Ozempic vs Wegovy: Same Molecule, Different Doses
Summary: Both are semaglutide products by Novo Nordisk. Ozempic is approved for type 2 diabetes; Wegovy is the higher-dose version approved specifically for weight management. Many providers prescribe Ozempic off-label for weight loss.
Side-by-Side Comparison
| Category | Ozempic | Wegovy |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| FDA indication | Type 2 diabetes | Chronic weight management |
| FDA approval year | 2017 | 2021 |
| Maximum dose | 2mg | 2.4mg |
| Insurance coverage | Covered for diabetes | Varies; often not covered for obesity alone |
| Medicare Part D | Covered (diabetes) | Not covered (weight loss) |
| Off-label weight loss use | Common | N/A (on-label) |
This comparison is for informational purposes only and does not constitute medical advice. Consult a healthcare provider for personalized guidance.